CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,856 | -99.9% | 16,800 | -44.9% | 0.00% | – |
| Q3 2022 | $3,003,000 | +74975.0% | 30,500 | +100.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 15,250 | -3.2% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 15,750 | -18.2% | 0.00% | – |
| Q4 2021 | $12,000 | -50.0% | 19,250 | -18.4% | 0.00% | – |
| Q3 2021 | $24,000 | -40.0% | 23,590 | +9.3% | 0.00% | – |
| Q2 2021 | $40,000 | -13.0% | 21,590 | -8.4% | 0.00% | -100.0% |
| Q1 2021 | $46,000 | +27.8% | 23,570 | -15.0% | 0.00% | – |
| Q4 2020 | $36,000 | -99.9% | 27,740 | -19.3% | 0.00% | -100.0% |
| Q3 2020 | $62,000,000 | – | 34,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |